维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="Trümper"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma:6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group显示文摘	Pfreundschuh M Kuhnt E Trümper L		0，，11：	1
2	CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma:6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group显示文摘	Pfreundschuh M Kuhnt E Trümper L		0，，11：	1
3	CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lym-phoma:6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group显示文摘	Pfreundschuh M Kuhnt E Trümper L		0，，11：	1
4	CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma:a randomised controlled trial by the MabThera International Trial (MInT) Group显示文摘	Pfreundschuh M Trümper L Osterborg A		0，，：	1
5	Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas:results of the NHL-B2 trial of the DSHNHL显示文摘	Pfreundschuh M Trümper L Kloess M	2004	Blood2004，104，3：	1
6	2-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas:results of the NHLB2 trial of the DSHNHL显示文摘	Pfreundschuh M Trümper L Kloess M	2004	Blood2004，104，：	1
7	Twoweekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good prognosis (normal LDH) aggressive lymphomas:results of the NHL-B1 trial of the DSHNHL显示文摘	Pfreundschuh M Trümper L Kloess M	2004	Blood2004，104，：	1
8	Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas:results of the NHL-B2trial of the DSHNHL显示文摘	Pfreundschuh M Trümper L Kloess M	2004	Blood2004，104，3：	1
9	CHOP-likechemotherapy plus rituximab versus CHOP-like chemotherapy a-lone in young patients with good-prognosis diffuse large-B-celllymphoma:a randomised controlled trial by the MabThera Inter-national Trial(MInT)Group显示文摘	Pfreundschuh M Trümper L Osterbor A	2006	Lancet Oncol2006，7，：	1
10	Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group显示文摘	Schmitz N Trümper L Ziepert M	2010	Blood2010，116，18：	1
11	Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas显示文摘	Michael Pfreundschuh Lorenz Trümper Marita Kloess	2004	Blood2004，104，：	1
12	CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group显示文摘	Pfreundschuh M Trümper L Osterborg A	2006	Lancet Oncol2006，7，5：	1
13	CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma:a randomised controlled trial by the MabThera International Trial(MInT)Group显示文摘	Pfreundschuh M Trümper L Osterborg A	2006	Lancet Oncol2006，7，：	1
14	Chop-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma:a randomized controlled trial by the MabThera International Trial (MInT) Group显示文摘	Pfreundsc M Trümper L Osterborg A	2006	Lancet Oncol2006，7，：	1
15	Randomized intergroup trial of first line treatment for patients ≤60 years with diffuse large B-cell non-Hodgkin's lymphoma(DLBCL) with a CHOP-like regimen with or without the anti-CD20 antibody rituximab - early stopping after the first interim analysis显示文摘	Pfreundschuh MG Trümper L Ma D	2004	Proc Am Soc Clin Oncol2004，，：	1
16	Nicotineinhibits large conductance Ca2+-activated K+channels and the NO/-cGMP signaling pathway in cultured human endothe-lial cells显示文摘	Kuhlmann C R Trümper J R Tillmanns H	2005	Scand Cardiovasc J2005，39，6：	1
17	CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma:6 year results of an open-label randomised study of the MabThera International Trial (MInT) Group显示文摘	Pfreundschuh M Kuhnt E Trümper L	2011	Lancet Oncol2011，12，11：	1
18	CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma:6-year results of an open-label randomised study of the Mab-Thera International Trial(MInT)Group显示文摘	Pfreundschuh M Kuhnt E Trümper L	2011	Lancet On-col2011，12，11：	1
19	Romdomized intergroup trial of first line treatment for patients ≤60 years with diffuse large B-cell non-Hodgkin-s lymphoma(DLBCL) with a CHOP-like regimen with or without the anti-CD20 antibody rituximab-early stopping after the first interim analysis显示文摘	Pfreundschuh MG Trümper L Ma D	2004	J Clin Oncol2004，22，14：	1
20	Treatment and prognosis of mature T-cell and NK-cell lymphoma:an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group显示文摘	Schmitz N Trümper L Ziepert M	2010	Blood2010，116，18：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示